Communications Biology (Jun 2021)

Cyanocobalamin prevents cardiomyopathy in type 1 diabetes by modulating oxidative stress and DNMT-SOCS1/3-IGF-1 signaling

  • Masao Kakoki,
  • Purushotham V. Ramanathan,
  • John R. Hagaman,
  • Ruriko Grant,
  • Jennifer C. Wilder,
  • Joan M. Taylor,
  • J. Charles Jennette,
  • Oliver Smithies,
  • Nobuyo Maeda-Smithies

DOI
https://doi.org/10.1038/s42003-021-02291-y
Journal volume & issue
Vol. 4, no. 1
pp. 1 – 12

Abstract

Read online

Kakoki et al report a role for cyanocobalamin (B12) in preventing cardiomyopathy in type 1 diabetic mice, by reducing levels of reactive oxygen species and restoring IGF-1 levels via DNMT-SOCS1/3 signalling. The authors therefore propose B12 as a promising option to prevent diabetic cardiomyopathy through its cardioprotective effects.